Earnings NewsHealthcareOsiris Therapeutics beats by $0.02, beats on revenuesMay 12, 2014 6:07 PM ETOsiris Therapeutics, Inc. (OSIR) StockBy: Gaurav Batavia, SA News Editor Osiris Therapeutics (NASDAQ:OSIR): Q1 EPS of -$0.02 beats by $0.02. Revenue of $10.1M (+146% Y/Y) beats by $1.35M. Press Release Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgOSIR--Osiris Therapeutics, Inc.Trending AnalysisTrending News